Interestingly he also told us in that presentation they are already talking to big pharma. It was regarding the AD,PD pre clinical work, it went something like this. " There are several models we can use so we have discussed with Big Pharma what they want to see" [Rough translation]
I guess it's possible that's all they discussed. But I think it unlikely, it's much more likely both parties would be keen to discuss the whole package. Keeping in mind discussions are not negotiations. But one leads to the other.
Disclaimer; I'm not saying we will get an offer tomorrow, I really have no idea. But it is possible, and will be influenced by may things on the BP side like their risk aversion and confidence in MPL. But the longer they wait, the more they will pay, while risking another company slipping in under their guard.
Cheers
- Forums
- ASX - By Stock
- PAA
- PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-644
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.5¢ |
Change
0.010(4.88%) |
Mkt cap ! $95.68M |
Open | High | Low | Value | Volume |
21.5¢ | 22.0¢ | 21.5¢ | $378.8K | 1.759M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13800 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 191261 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13800 | 0.215 |
6 | 304678 | 0.210 |
5 | 257125 | 0.205 |
15 | 540770 | 0.200 |
7 | 254593 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 191261 | 5 |
0.225 | 2084 | 1 |
0.230 | 54360 | 2 |
0.240 | 134752 | 2 |
0.245 | 270545 | 4 |
Last trade - 14.00pm 15/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online